Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$0.4 - $0.91 $3,738 - $8,505
-9,347 Reduced 2.24%
408,432 $216,000
Q4 2023

Feb 09, 2024

SELL
$0.71 - $0.97 $104,693 - $143,031
-147,455 Reduced 26.09%
417,779 $380,000
Q3 2023

Nov 13, 2023

SELL
$0.96 - $2.01 $91,626 - $191,842
-95,444 Reduced 14.45%
565,234 $553,000
Q2 2023

Aug 10, 2023

BUY
$1.59 - $2.29 $404,645 - $582,791
254,494 Added 62.65%
660,678 $1.16 Million
Q1 2023

May 09, 2023

BUY
$2.05 - $2.87 $832,677 - $1.17 Million
406,184 New
406,184 $926,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.